Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Thrombocytopenia and CYP2C9[original query] |
|---|
| Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days. Cancer science 2005 Oct 96 (10): 721-8. Yamada Yasuhide, Yamamoto Noboru, Shimoyama Tatsu, Horiike Atsushi, Fujisaka Yasuhito, Takayama Kyoko, Sakamoto Terumi, Nishioka Yuki, Yasuda Sanae, Tamura Tomohi |
| Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy. Epilepsy research 2017 1 130 7-12. Jogamoto Toshihiro, Yamamoto Yoshiaki, Fukuda Mitsumasa, Suzuki Yuka, Imai Katsumi, Takahashi Yukitoshi, Inoue Yushi, Ohtsuka Yo |
| CYP2J27 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients. Frontiers in pharmacology 2019 5 10 481. Ahmed Jemal Hussien, Makonnen Eyasu, Yimer Getnet, Seifu Daniel, Bekele Abebe, Assefa Mathewos, Aseffa Abraham, Howe Rawleigh, Fotoohi Alan, Hassan Moustapha, Aklillu Ele |
| The Effect of CYP2C19*2 (rs4244285) and CYP17 (rs743572) SNPs on Adriamycin and Paclitaxel based Chemotherapy Outcomes in Breast Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2024 6 25 (6): 1977-1986. Rashmi A Gudur, Suresh J Bhosale, Anand K Gudur, Shivani R Kale, Ashwini L More, Kailas D Datkhi |
- Page last reviewed:Feb 1, 2024
- Content source: